Back to News
Market Impact: 0.4
Stryker (NYSE: SYK) Scrutinized Amid Disclosure of Persisting Peripheral Vascular Problems -- HBSS
Source: globenewswire.com
Company FundamentalsManagement & GovernanceLegal & LitigationHealthcare & Biotech
Stryker shares fell $26.70, or 8.8%, on September 8 after its CFO disclosed that a manufacturing issue previously believed to be resolved remains ongoing. The disclosure raises operational-execution and potential legal-risk concerns for the medical-device company.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
strongly negative
Sentiment Score
-0.55
Ticker Sentiment
SYK-0.85
More News
- CoreWeave seeks truce with Texas Governor-elect Hinojosa
- These funds tout hefty income tied to the tech trade – if you’re willing to deal with the complexity
- Street Calls of The Week
- Meta’s $25 Billion Bond Sale Highlights Shifting Landscape for Tech Debt
- Binance CFO exits days after catastrophic $6 billion crypto hack
- Coffee giant Dutch Bros made all of its executives, including the CEO, do a two-week bootcamp where they learned how to pour drinks and run stores